Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Post by flush777on Apr 12, 2021 10:59am
409 Views
Post# 32977145

Microsoft Buys Nuance For $19.7 Billion, Bet on Health Care

Microsoft Buys Nuance For $19.7 Billion, Bet on Health Care

(Bloomberg) -- Microsoft Corp. is buying speech technology company Nuance Communications Inc. in an all-cash deal valued at $19.7 billion, making a massive bet on health care artificial intelligence.

The software giant is offering to purchase Nuance at $56 a share, a 23% premium to Friday’s close, according to a statement Monday, which confirmed an earlier Bloomberg report. The deal marks Microsoft’s largest acquisition since LinkedIn Corp.

Microsoft is tapping the company tied to the Siri voice technology to develop solutions that free doctors from note-taking and better predict a patient’s needs. It has been working with Nuance for two years on AI software that helps clinicians capture patient discussions and integrate them into electronic health records, and combining the speech technology company’s products into its Teams chat app for telehealth appointments.

©2021 Bloomberg L.P.

https://www.bnnbloomberg.ca/microsoft-buys-nuance-for-19-7-billion-in-bet-on-health-care-1.1589043

<< Previous
Bullboard Posts
Next >>